NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization354.43 mln
Float27.87 mln
Earnings Date11/11/2026
1-Year Forecast
20.86
Transformational upside
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-32.06
Deeply negative
ROA
-30.33
Deeply negative
Business Description
Sionna Therapeutics Inc. is a Waltham, Massachusetts-based company founded in 2019 and focused solely on finding better treatments for cystic fibrosis. The company has built a broad pipeline of experimental drugs, several of which have already advanced through early and mid-stage clinical trials. Each drug candidate targets a different part of the protein responsible for cystic fibrosis, with the goal of offering patients more effective options than those currently available.
